BETHESDA, MD, September 20, 2022 – CareMetx, LLC, a leading technology-enabled services company focused on improving patient access to specialty medications, has announced the appointment of Nasir Ali as the Company’s Chief Product Officer. Ali is a growth-oriented product and solution management executive with a track record of providing strategic and tactical leadership across the […]
Category: Press Release
CareMetx Announces Addition of Rita Kale to Board of Directors
Kale brings more than 20 years’ experience in healthcare and financial leadership. BETHESDA, MD, July 26, 2022 – CareMetx, LLC, a leading technology-enabled services company focused on improving patient access to specialty medications, today announced that Rita Kale has joined the company’s board of directors. Kale brings over two decades of global healthcare industry experience, with […]
CareMetx Announces Executive Leadership Updates to Accelerate Next Phase of Growth
Jim Rowe joins as President and CEO, bringing more than 20 years of experience in healthcare technology Mark Hansan, Co-founder, to assume Executive Chairman role Bethesda, Maryland, June 14, 2022 – CareMetx, LLC, a leading technology-enabled hub services company focused on improving patient access to specialty medications, today announced executive leadership updates as the senior […]
CareMetx and United Rheumatology Partner to Better Support Patients Who Suffer From Numerous Chronic Inflammatory Diseases
Through this partnership, CareMetx will activate their intelligent prescription management solutions for both pharmacy and medical benefit products within United Rheumatology’s network of Providers. […]
CareMetx Acquires Human Care Systems to deliver best-in-class patient services offering
Strategic acquisition of leading patient adherence technology and services provider to complement CareMetx current suite of patient access products. […]
CareMetx Partners with Emerging Therapy Solutions (ETS) to Address High Cost of Therapy for Rare Genetic Diseases
CareMetx’s subsidiary OutcomeRx Insurance Management Services,LLC will leverage access to the Emerging Therapy Solutions (ETS) nationwide network of over 120 medical centers, in order to bolster their Patient Access to Costly and Curative Therapies (PACCT) product, one designed to help payers manage the sudden, high costs of therapies for rare genetic diseases. Bethesda, MD, Nov. […]
Veradigm Partners with CareMetx, LLC to Optimize End-to-End Specialty Medication Access and Services Streamlining Patient Care
New Strategic Partnership Will Simplify and Accelerate Specialty Approval Medication Process CHICAGO – OCTOBER 5, 2021 — Veradigm®, a leading provider of healthcare data and technology solutions a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and CareMetx, a leading technology-enabled hub services company focused on improving patient access to specialty medications, announced today a new […]
CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company
CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company CareMetx Announces Acquisition of Phyz Healthcare Solutions, a Digital Healthcare Company The acquisition of Phyz Healthcare Solutions offers clients exposure to an expanded network of providers by embedding access to specialty therapies directly into the prescriber workflow. CareMetx, a leading technology-enabled hub services company […]
CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership
CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership CareMetx, General Atlantic and The Vistria Group Announce Strategic Growth Partnership Significant investment from General Atlantic and The Vistria Group positions CareMetx for continued growth in supporting patient access to innovative therapies Bethesda, MD, New York, NY and Chicago, IL – January 14, 2021 […]
OutcomeRx, a division of CareMetx, LLC announces First Independent Reinsurance Product for Rare Disease Specialty, Cell and Gene Therapies
Launch of new reinsurance product will help payers manage sudden, high costs of therapies for rare genetic diseases with goal of reducing access and affordability challenges for patients Bethesda, MD (October 28, 2020) – OutcomeRx (ORx), a division of CareMetx, LLC, announced today a new reinsurance product to provide coverage access to high-cost specialty drugs […]